These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 11859520

  • 1. [Treatment of spasticity].
    Autti-Rämö I.
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract] [Full Text] [Related]

  • 2. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
    Charles PD, Gill CE, Taylor HM, Putman MS, Blair CR, Roberts AG, Ayers GD, Konrad PE.
    Mov Disord; 2010 Mar 15; 25(4):466-73. PubMed ID: 20131401
    [Abstract] [Full Text] [Related]

  • 3. Managing spasticity with drugs.
    Simon O, Yelnik AP.
    Eur J Phys Rehabil Med; 2010 Sep 15; 46(3):401-10. PubMed ID: 20927006
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI, Wasay M, Awan S.
    J Child Neurol; 2008 Dec 15; 23(12):1464-6. PubMed ID: 19073853
    [Abstract] [Full Text] [Related]

  • 5. New approaches to managing spasticity in children with cerebral palsy.
    Im D, McDonald CM.
    West J Med; 1997 Apr 15; 166(4):271. PubMed ID: 9168686
    [No Abstract] [Full Text] [Related]

  • 6. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W.
    Wien Klin Wochenschr; 2001 Apr 15; 113 Suppl 4():30-5. PubMed ID: 15506050
    [Abstract] [Full Text] [Related]

  • 7. Anti-spasticity medications.
    Al-Shahrani AM.
    Saudi Med J; 2003 Jan 15; 24(1):19-22. PubMed ID: 12590267
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic interventions for reducing spasticity in cerebral palsy.
    Patel DR, Soyode O.
    Indian J Pediatr; 2005 Oct 15; 72(10):869-72. PubMed ID: 16272661
    [Abstract] [Full Text] [Related]

  • 9. [New therapies for spastic movement disorders].
    Benecke R, Patejdl R.
    MMW Fortschr Med; 2009 Oct 15; 151 Suppl 3():118-22. PubMed ID: 20623938
    [No Abstract] [Full Text] [Related]

  • 10. Drug treatments for spasticity.
    Yelnik AP, Simon O, Bensmail D, Chaleat-Valayer E, Decq P, Dehail P, Quentin V, Marque P, Parratte B, Pellas F, Rousseaux M, Trocello JM, Uzzan M, Dumarcet N, Agence française de sécurité sanitaire des produits de santé.
    Ann Phys Rehabil Med; 2009 Dec 15; 52(10):746-56. PubMed ID: 19892619
    [No Abstract] [Full Text] [Related]

  • 11. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
    Marvulli R, Lagioia G, Ianieri G, Dell'Olio L, Zonno A, Riccardi M, Sinisi RB, Rizzo LB, Farì G, Megna M, Ranieri M.
    CNS Neurol Disord Drug Targets; 2024 Dec 15; 23(7):917-926. PubMed ID: 38213169
    [Abstract] [Full Text] [Related]

  • 12. Intrathecal baclofen in the management of spasticity due to cerebral palsy.
    Vloeberghs M, Keetley R, Morton R.
    Pediatr Rehabil; 2005 Dec 15; 8(3):172-9. PubMed ID: 16087551
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R, Calderón-Sepúlveda RF.
    Rev Neurol; 2005 Dec 15; 34(1):52-9. PubMed ID: 11988892
    [Abstract] [Full Text] [Related]

  • 15. [Botulinum toxin Type A. Indications and results].
    Póo P, López-Casas JA, Galván-Manso M, Aquino-Fariña L, Terricabras-Carol L, Campistol J.
    Rev Neurol; 2005 Dec 15; 37(1):74-80. PubMed ID: 12861515
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O, Monteil-Roch I.
    Rev Neurol (Paris); 2012 Apr 15; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [Abstract] [Full Text] [Related]

  • 17. [Clinical treatment (non surgical) of spasticity in cerebral palsy].
    Calderón-González R, Calderón-Sepúlveda RF.
    Rev Neurol; 2012 Apr 15; 34(1):1-6. PubMed ID: 11988886
    [Abstract] [Full Text] [Related]

  • 18. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW, Cole LL, Liptak GS.
    Phys Ther; 2006 Apr 15; 86(4):573-84. PubMed ID: 16579673
    [No Abstract] [Full Text] [Related]

  • 19. An approach to switching patients from baclofen to tizanidine.
    Brenner R, Hyman N, Knobler R, O'Brien M, Stephan T.
    Hosp Med; 1998 Oct 15; 59(10):778-82. PubMed ID: 9850294
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT, Doherty GM, Fairhurst CB.
    Dev Med Child Neurol; 2009 Sep 15; 51(9):705-10. PubMed ID: 19459910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.